![PDF) Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: Results from a Gruppo PDF) Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: Results from a Gruppo](https://i1.rgstatic.net/publication/275101627_Predicting_poor_peripheral_blood_stem_cell_collection_in_patients_with_multiple_myeloma_receiving_pre-transplant_induction_therapy_with_novel_agents_and_mobilized_with_cyclophosphamide_plus_granulocyt/links/559bdbd808ae898ed650a749/largepreview.png)
PDF) Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: Results from a Gruppo
![Enhancement of terbium efficiency by gallium and copper co-doping in (Pr, Nd)-Fe-B sintered magnets - ScienceDirect Enhancement of terbium efficiency by gallium and copper co-doping in (Pr, Nd)-Fe-B sintered magnets - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1002072122001090-ga1.jpg)
Enhancement of terbium efficiency by gallium and copper co-doping in (Pr, Nd)-Fe-B sintered magnets - ScienceDirect
![IJMS | Free Full-Text | The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives IJMS | Free Full-Text | The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives](https://www.mdpi.com/ijms/ijms-21-06830/article_deploy/html/images/ijms-21-06830-g001.png)
IJMS | Free Full-Text | The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives
![A clinician's guide to double hit lymphomas - Cheah - 2015 - British Journal of Haematology - Wiley Online Library A clinician's guide to double hit lymphomas - Cheah - 2015 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b5570391-10c4-4c13-9102-77da075ea161/bjh13276-tbl-0002-m.jpg)
A clinician's guide to double hit lymphomas - Cheah - 2015 - British Journal of Haematology - Wiley Online Library
![Survival estimates plotted by NCCN categories of risk. (A) Two-year OS... | Download Scientific Diagram Survival estimates plotted by NCCN categories of risk. (A) Two-year OS... | Download Scientific Diagram](https://www.researchgate.net/publication/335065872/figure/fig1/AS:916090204983297@1595424333930/Survival-estimates-plotted-by-NCCN-categories-of-risk-A-Two-year-OS-was-42-58-74.png)
Survival estimates plotted by NCCN categories of risk. (A) Two-year OS... | Download Scientific Diagram
Inflammatory Markers and Development of Symptom Burden in Patients with Multiple Myeloma during Autologous Stem Cell Transplanta
Varios - Estetica Y Emancipacion Fantasma Fetiche Y Fantasmagoria-2 | PDF | Galileo Galilei | Cuerpos del sistema solar
![Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram](https://www.researchgate.net/publication/328751184/figure/fig3/AS:958789662568489@1605604677701/Overall-survival-OS-and-progression-free-survival-PFS-from-time-of-ASCT-Median-OS_Q640.jpg)
Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram
![Overall survival (OS) and progression-free survival (PFS) in patients... | Download Scientific Diagram Overall survival (OS) and progression-free survival (PFS) in patients... | Download Scientific Diagram](https://www.researchgate.net/publication/328751184/figure/fig4/AS:958789662560280@1605604677804/Overall-survival-OS-and-progression-free-survival-PFS-in-patients-undergoing-deferred.png)
Overall survival (OS) and progression-free survival (PFS) in patients... | Download Scientific Diagram
![Patients demographics and clinico-biologic characteristics according to... | Download Scientific Diagram Patients demographics and clinico-biologic characteristics according to... | Download Scientific Diagram](https://www.researchgate.net/profile/Francesco-Lanza-3/publication/335065872/figure/tbl1/AS:916090204999685@1595424333997/Patients-demographics-and-clinico-biologic-characteristics-according-to-treatment-received_Q640.jpg)
Patients demographics and clinico-biologic characteristics according to... | Download Scientific Diagram
![PDF) Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance: Synchronous CNS PDF) Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance: Synchronous CNS](https://www.researchgate.net/profile/Dipti-Talaulikar/publication/334005541/figure/fig2/AS:829665350524931@1574819042253/A-Progression-free-survival-according-to-receipt-of-consolidative-AuSCT-in-first_Q320.jpg)
PDF) Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance: Synchronous CNS
![Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial | Request PDF Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial | Request PDF](https://i1.rgstatic.net/publication/350574669_Minocycline_for_symptom_reduction_in_patients_with_multiple_myeloma_during_maintenance_therapy_a_phase_II_placebo-controlled_randomized_trial/links/6066a60e458515614d2b843e/largepreview.png)
Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial | Request PDF
![Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram](https://www.researchgate.net/publication/328751184/figure/fig3/AS:958789662568489@1605604677701/Overall-survival-OS-and-progression-free-survival-PFS-from-time-of-ASCT-Median-OS.png)
Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram
![Serum of inflammatory markers by treatment groups (mean, 95% confidence... | Download Scientific Diagram Serum of inflammatory markers by treatment groups (mean, 95% confidence... | Download Scientific Diagram](https://www.researchgate.net/publication/334062196/figure/fig2/AS:1002674040344578@1616067528598/Serum-of-inflammatory-markers-by-treatment-groups-mean-95-confidence-interval.jpg)
Serum of inflammatory markers by treatment groups (mean, 95% confidence... | Download Scientific Diagram
![Cancers | Free Full-Text | Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma Cancers | Free Full-Text | Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma](https://www.mdpi.com/cancers/cancers-13-04666/article_deploy/html/images/cancers-13-04666-g001.png)
Cancers | Free Full-Text | Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma
Full article: The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution
![European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias | Leukemia European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-018-0209-7/MediaObjects/41375_2018_209_Fig1_HTML.png)